Posts by Sandra Ansanay-Alex
A New Centre to Advance Cardiovascular Research in Geneva
University of Geneva Faculty of Medicine has launched the Geneva Centre for Cardiac and Vascular Research (GCCVR).
Read MoreNourishAI, GenoRobotics and Infera Neuro Get Support from the EPFL Startup Launchpad
Three EPFL-born startups receive key funding to advance breakthrough technologies in health and biology.
Read MoreReverso Therapeutics Secures CHF 710,000 Innosuisse Grant
Reverso Therapeutics, a University of Geneva (UNIGE) pharmaceutical spin-off, and winner of the Bioinnovation Day Best Academic Project Award 2025, has been awarded a CHF 710,000 grant from Innosuisse to accelerate the development of its breakthrough reversible anticoagulant technology.
Read MoreAltiscreen receives CHF 150,000 from Venture Kick
The Jura-based medtech startup Altiscreen has obtained CHF 150,000 from Venture Kick to build a portable drug-testing solution that delivers clear results in just three minutes. Its device is designed to support roadside checks, workplace screening, and mobile healthcare teams that need reliable information on the spot. Every day, delayed or unreliable field drug tests…
Read MoreDatabaum and Lemna Bio Receive a Tech Seed Loan from FIT
Two Tech Seed loans of CHF 100,000 each were awarded by FIT to Databaum , an artificial intelligence platform for farmers that transforms raw data from the field into intelligent decisions; and to Lemna Bio, where artificial intelligence is used to understand biological interactions. databaum: data intelligence for regenerative agriculture Agriculture can only be truly…
Read MorePOSICS, Geneva Connection Technologies and Vectopia awarded FIF Grants
Two projects from the University of Geneva and one project from CERN have each been awarded CHF 50,000 in funding from the Fonds pour l’Innovation et le Futur de Genève (FIF). The recipients include a spin-off from the Faculty of Science, POSICS; a spin-off from the Faculty of Medicine, Vectopia; and a spin-off from CERN,…
Read MoreBio-Techne partners with Wyss Center Geneva
Bio-Techne (formerly Lunaphore) has announced a strategic partnership between its spatial biology brand Lunaphore and the Wyss Center Geneva to advance automated 3D multiomics — a major leap forward for biomedical research. This collaboration aims to automate simultaneous RNA and protein detection in 3D tissue specimens, lowering technical barriers and unlocking deeper insights into tissue…
Read MoreDigeHealth secures CHF 1.25 million seed round to transform gastro-intestinal monitoring
DigeHealth SA, a Swiss medtech company developing a wearable device that “listens to the gut” to support early detection and management of gastro-intestinal complications, announced the successful closing of a CHF 1.25 million seed round. The round was led by Medin Fund Management with the participation of Lichtsteiner Foundation and will enable DigeHealth to accelerate…
Read MoreStudentsPool wins the 10th Patient Quality of Life Challenge
Led by Isa Dupont, a nurse, and Gaspard Chevassus, an engineer, the StudentsPool project is reinventing ad hoc recruitment and connecting students with healthcare institutions to offer assignments serving patients. The project, selected among 5 finalists, received a CHF 25,000 support. The constant turnover of temporary staff undermines the quality of care. Faced with this…
Read MoreEspeRare receives a grant from the Gates Foundation
EspeRare, a pioneering Geneva-based nonprofit biotech, announced that it has been awarded a Grand Challenges grant from the Gates Foundation. This milestone strengthens EspeRare’s mission to bring life-changing therapies to patients in under-resourced settings worldwide. The Grand Challenges initiative, funded by the Gates Foundation, supports bold ideas that drive innovation to address pressing global health…
Read More